Genmab says Q3 2026 DARZALEX net sales totaled $4.24 billion
GMAB•Worldwide net trade sales of DARZALEX totaled $4.24 billion in Q3 2026, including $2.53 billion in the U.S. and $1.71 billion elsewhere.
1. DARZALEX sales
Genmab reported worldwide net trade sales of DARZALEX of $4.24 billion in the third quarter of 2026. Johnson & Johnson reported the sales under its license agreement with Genmab, which receives royalty income tied to worldwide DARZALEX net sales.
